Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia

American Journal of Surgical Pathology

Volumn 32, Issue 4, 2008, Pages 502-512

  Horn, Lars Christian ^a   Reichert, Anja ^b   Oster, Anne ^g   Arndal, Sanne Frost ^g   Trunk, Marcus J ^b   Ridder, Ruediger ^b   Rassmussen, Ole Feldballe ^g   Bjelkenkrantz, Kaj ^j   Christiansen, Pernille ^h   Eck, Matthias ^c   Lorey, Thomas ^d   Skovlund, Vibeke Ravn ⁱ   Ruediger, Thomas ^c   Schneider, Volker ^e   Schmidt, Dietmar ^f,k  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MTM Laboratories   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Institute of Pathology   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f Institute of Pathology   (Germany)

^g AGILENT TECHNOLOGIES   (United States)

^h Department of Pathology   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k Institut fur Pathologie   (Germany)

more..

Author keywords

Cervical neoplasms; CIN; Diagnostic performance; Immunohistochemistry; Interobserver agreement; P16INK4a; Quality control

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EOSIN; HEMATOXYLIN; COLORING AGENT; DIAGNOSTIC AGENT; TUMOR MARKER;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; STAINING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; BIOPSY; CHEMISTRY; COMPARATIVE STUDY; FEMALE; OBSERVER VARIATION; PATHOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; UPREGULATION; UTERINE CERVIX TUMOR;

BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLORING AGENTS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 41449099879     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31815ac420     Document Type: Article

References (26)

1. Agoff SN, Lin P, Morihara J, et al. p16INK4a expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 2003;16:665-673.
2. Cocker J, Fox H, Langley FA. Consistency in the histological diagnosis of epithelial abnormalities of the cervix uteri. J Clin Pathol. 1968;21:67-70.
3. Creagh T, Bridger JE, Kupek E, et al. Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia. J Clin Pathol. 1995;48:59-60.
4. de Vet HC, Koudstaal J, Kwee WS, et al. Efforts to improve interobserver agreement in histopathological grading. J Clin Epidemiol. 1995;48:869-873.
5. Grenko RT, Abendroth CS, Frauenhoffer EE, et al. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. Am J Clin Pathol. 2000;114:735-740.
6. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2000.
7. Ismail SM, Colclough AB, Dinnen JS, et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ. 1989;298:707-710.
8. Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol. 2001;8:83-92.
9. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4a are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-891.
10. Keenan SJ, Diamond J, McCluggage WG, et al. An automated machine vision system for the histological grading of cervical intraepithelial neoplasia (CIN). J Pathol. 2000;192:351-362.
11. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
12. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26:1389-1399.
13. McCluggage WG, Walsh MY, Thornton CM, et al. Inter- and intraobserver variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol. 1998;105:206-210.
14. Murphy N, Ring M, Killalea AG, et al. p16INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol. 2003;56:56-63.
15. Murphy N, Ring M, Heffron CC, et al. p16INK4a, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol. 2005;58:525-534.
16. Negri G, Egarter-Vigl E, Kasal A, et al. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol. 2003;27:187-193.
17. Ringsted J, Amtrup F, Asklund C, et al. Reliability of histopathological diagnosis of squamous epithelial changes of the uterine cervix. Acta Pathol Microbiol Scand (A). 1978;86:273-278.
18. Robertson AJ, Anderson JM, Beck JS, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol. 1989;42:231-238.
19. Sano T, Oyama T, Kashiwabara K, et al. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int. 1998;48:580-585.
20. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741-1748.
21. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002;52:375-383.
22. Stoler MH. Advances in cervical screening technology. Mod Pathol. 2000;13:275-284.
23. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
24. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol. 2004;35:689-696.
25. Wang SS, Trunk M, Schiffman M, et al. Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomarkers Prev. 2004;13:1355-1360.
26. Wells M, Oestoer AG, Crum CP, et al. Tumours of the uterine cervix: epithelial tumours. In: Tavassoli FA, Devilee P, eds. Pathology and Genetics Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, No 4. Lyon: IARC Press; 2003.